Kasvu Therapeutics
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
€30MSeries A
ParticipantSI
Stephen Industries
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Jul 19, 2026
Stephen Industries is the corporate investor named by AlixLabs and in Kasvu financing coverage.
Recorded funding activity
AlixLabs develops semiconductor etching processes. Kasvu develops non-hallucinogenic neuroplasticity treatments, while Anferra recycles steel waste. The records retain distinct technologies and keep unpublished participation in draft.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $34.1M 1 disclosed · full round size, not this investor’s share